CClinicalTrials.gg
CompletedNCT03125252DELIREAUpdated Nov 12, 2020

Impact of Non-pharmacological Prevention Measures on the Incidence of Delirium in Adult Intensive Care Units

An interventional study of Bundle and Standard Paramedical and Medical practices in Delirium, sponsored by University Hospital, Toulouse. Completed at 14 sites in France. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2020-11-12.

Sponsored by University Hospital, Toulouse · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Oct 2016, registered Mar 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
379
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The main objective is to evaluate the impact of the "bundle of actions" on the delirium's incidence in resuscitation patients during their stay in the service, compared to a conventional treatment.

The investigators therefore hypothesize that a set of coordinated paramedical actions in the prevention of delirium would reduce its incidence by 15% compared to conventional care.

Read the detailed description

The "Bundle of Actions" is a coordinated and specific action plan, which has already been validated, focusing on the coordination of wake-up and respiration, the management of delirium, as well as the early mobility of the patient. Innovation consists of simple, reproducible nursing care that reduces triggers of delirium; as well as the use of two new approaches in reanimation: conversational hypnosis and early and comprehensive re-empowerment of the patient in the management of his pain and well-being.

02

Conditions studied

  • Delirium

Browse trials for

Keywords

  • Delirium
  • Reanimation
  • Conversational hypnosis
03

In context

Delirium

1,057 studies on the registry are indexed under Delirium; 238 are open to participants now.

This study's enrollment of 379 is above the median of 120 across 599 interventional studies indexed under Delirium.

Browse Delirium studies →

Lead sponsor

University Hospital, Toulouse is the lead sponsor of 794 studies on the registry; 214 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Informed consent signed by the trusted person and the patient upon waking
  • Hospitalized in reanimation service (first hospitalization or transfer of another service)
  • 48 hours of sedation with intubation during hospitalization (all combinations of morphine, hypnotics, sedatives, anesthetics, narcoleptics)
  • Francophone (able to understand all evaluations)

Criteria for the inclusion of 50 delirium positive patients drawn from the Toulouse center (participating in the neuropsychological evaluation): In addition to those mentioned above:

  • Absence of pre-existing cognitive impairment (patients whose relative has completed the IQCode questionnaire and whose score is \<3.4 points)
  • Visual, auditory (authorized equipment) skills and adequate oral or written expression for the proper conduct of neuropsychological tests.

Exclusion criteria

Exclusion Criteria:

  • Pregnant women
  • Evolutive neurological disease leading to cognitive impairment (multiple sclerosis, Parkinson's disease, Alzheimer's disease), and / or focal neurological disease leading to cognitive impairment (head trauma, stroke, ...)
  • Evolving psychiatric illness (including severe depression)
  • Voluntary drug poisoning
  • Patients who have already participated in the study
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
379 participants (actual)

Study arms

  • Experimental
    Bundle

    Specific action plan : ABCDE, complemented with care related to the nursing and paramedical role concerning the patient's environmental factors

    Other: Bundle

  • Other
    Control

    Standard paramedical and medical practices

    Other: Standard Paramedical and Medical practices

Interventions

  • OtherBundle

    Awakening and Breathing Coordination Delirium monitoring and management (detection and management of delirium) Early mobility Factors of environment: * thirst * noise * pain and well-being * sleep * isolation

    Also known as: ABCDE

  • OtherStandard Paramedical and Medical practices

    The current recommendations recommend the following scheme: * Identification and correction of an organic cause / factors (sepsis, metabolic disorders, withdrawal syndrome, pain) * Use of non-pharmacological means (early mobilization, correction of sensory deficits, temporo-spatial reorientation strategies) * Use of reference antipsychotic pharmacological means

06

What researchers measure

Primary outcomes

  1. Incidence rate of delirium

    CAM-ICU Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) scale.

    Time frame: Day 60

Secondary outcomes

  1. Duration of the delirium between the diagnosis and the resolution of the delirium

    The duration of the delirium (in days) between the diagnosis and the resolution of the delirium will be done until 60 days of the stay of the patients in intensive care.

    Time frame: Day 60

  2. Evaluation of cognitive and psycho-behavioral functions.

    Cognitive and psycho-behavioral functions are usually evaluated by a corpus of test : * memory : Test of 5 words and Free Recall Test * executive : Fast Evaluation Battery for Executive Functions, Trail Making Test, Digit Span, Stroop and Verbal Fluences and Animals * praxis : Mahieux's Test * language : D0 80 * behavior : Montgomery's scale (depression), Starkstein's scale (apathy).

    Time frame: Day 60 and month 3

  3. Quality of life at one year

    The evaluation of 142 first patients delirium positive: the first 12 patients delirium positive in the 6 centers of the arm to which Toulouse will not belong, and the first 14 patients delirium positive in the 5 centers of the arm to which Toulouse will belong (Toulouse excluded), 1 year after the date of their inclusion in the study during their hospitalization in reanimation service. This evaluation of Quality of life of the first patients detected positive to delirium will be carried out using the validated French standardized questionnaire or Short Form 36 item (SF-36) which will be sent by post to the patient's home.

    Time frame: Year 1

07

Study locations

14 sites
  • Saint-André Hospital
    Bordeaux, 33000, France
  • Hospital Castres-Mazamet
    Castres, 81, France
  • Estaing Hospital
    Clermont-Ferrand, 63100, France
  • Gabriel Montpied
    Clermont-Ferrand, 63100, France
  • Nord Hospital
    Marseille, 13015, France
  • Saint-Joseph Hospital
    Marseille, 13285, France
  • Montauban Hospital
    Montauban, 82000, France
  • Hospital
    Montpellier, 34090, France
  • Caremeau Hospital
    Nîmes, 30929, France
  • Perpignan Hospital
    Perpignan, 66046, France
  • Jacques Puel Hospital
    Rodez, 12027, France
  • University Hospital Toulouse
    Toulouse, 31000, France
  • Oncologic Hospital
    Toulouse, 31059, France
  • Rangueil Hospital
    Toulouse, 31059, France
08

References and documents

Publications

  • Aissaoui Y, Zeggwagh AA, Zekraoui A, Abidi K, Abouqal R. Validation of a behavioral pain scale in critically ill, sedated, and mechanically ventilated patients. Anesth Analg. 2005 Nov;101(5):1470-1476. doi: 10.1213/01.ANE.0000182331.68722.FF. PubMed 16244013 ↗
  • Arend E, Christensen M. Delirium in the intensive care unit: a review. Nurs Crit Care. 2009 May-Jun;14(3):145-54. doi: 10.1111/j.1478-5153.2008.00324.x. PubMed 19366412 ↗
  • Balas MC, Vasilevskis EE, Burke WJ, Boehm L, Pun BT, Olsen KM, Peitz GJ, Ely EW. Critical care nurses' role in implementing the "ABCDE bundle" into practice. Crit Care Nurse. 2012 Apr;32(2):35-8, 40-7; quiz 48. doi: 10.4037/ccn2012229. PubMed 22467611 ↗
  • Chanques G, Payen JF, Mercier G, de Lattre S, Viel E, Jung B, Cisse M, Lefrant JY, Jaber S. Assessing pain in non-intubated critically ill patients unable to self report: an adaptation of the Behavioral Pain Scale. Intensive Care Med. 2009 Dec;35(12):2060-7. doi: 10.1007/s00134-009-1590-5. PubMed 19697008 ↗
  • Devlin JW, Brummel NE, Al-Qadheeb NS. Optimising the recognition of delirium in the intensive care unit. Best Pract Res Clin Anaesthesiol. 2012 Sep;26(3):385-93. doi: 10.1016/j.bpa.2012.08.002. PubMed 23040288 ↗
  • Ely EW, Shintani A, Truman B, Speroff T, Gordon SM, Harrell FE Jr, Inouye SK, Bernard GR, Dittus RS. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA. 2004 Apr 14;291(14):1753-62. doi: 10.1001/jama.291.14.1753. PubMed 15082703 ↗
  • Erickson MH, Rossi EL. Two level communication and the microdynamics of trance and suggestion. Am J Clin Hypn. 1976 Jan;18(3):153-71. doi: 10.1080/00029157.1976.10403794. No abstract available. PubMed 1246970 ↗
  • Girard TD, Pandharipande PP, Ely EW. Delirium in the intensive care unit. Crit Care. 2008;12 Suppl 3(Suppl 3):S3. doi: 10.1186/cc6149. Epub 2008 May 14. PubMed 18495054 ↗
  • Guenther U, Popp J, Koecher L, Muders T, Wrigge H, Ely EW, Putensen C. Validity and reliability of the CAM-ICU Flowsheet to diagnose delirium in surgical ICU patients. J Crit Care. 2010 Mar;25(1):144-51. doi: 10.1016/j.jcrc.2009.08.005. Epub 2009 Oct 13. PubMed 19828283 ↗
  • McCusker J, Cole MG, Voyer P, Monette J, Champoux N, Ciampi A, Vu M, Belzile E. Six-month outcomes of co-occurring delirium, depression, and dementia in long-term care. J Am Geriatr Soc. 2014 Dec;62(12):2296-302. doi: 10.1111/jgs.13159. Epub 2014 Dec 8. PubMed 25482152 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 12, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03125252
Lead sponsor
University Hospital, Toulouse
Responsible party
Sponsor
First posted
Apr 24, 2017
Start date
Oct 27, 2016
Primary completion
Apr 2020
Completion
Nov 2020
Last update
Nov 12, 2020

Study contacts

Fanny CROZES, nurse
study director · University Hospital, Toulouse

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion